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are structurally similar to PAHs but little information is available on
their toxic properties. Some indications suggest similar or higher
toxic potential than PAHs. The main objective of the present work
was to evaluate the toxicological properties of a number of PANHs
selected according to number of rings (3 up to 5) in comparison to
their respective PAH structural analogues.
We have applied an in vitro test battery covering activities con-
sidered of toxicological relevance for this group of chemicals:
- nuclear receptors activity/inhibition (e.g. Aryl Hydrocarbon
receptor (AhR) activation),
- genotoxicity potential (e.g. Gadd45, Histone phosphorylation),
- cell viability in presence or absence ofmetabolic activation (±S9).
Results with the well-characterized PAH reference, Benzo(a)-
pyrene were in agreement with literature data, conﬁrming the
suitability of the tests selected. There was no trend between cyto-
toxicity potency and either ring number or PANHs vs PAHs. The
most potent genotoxic chemicals were found amongst the high
number of ring chemicals, and in presence of S9. AhR activation
was themost sensitiveparameterwith adirect correlationbetween
potency and the ring number. There were no striking differences
between PANHs and PAHs for these parameters.
Compared to respective PAH analogues, the tested PANHs
exhibit similar toxicological proﬁles and are likely to raise similar
toxicological concern. However, PANHs may not bring signiﬁcant
additional risk burden since exposure seems much lower than for
PAHs.
http://dx.doi.org/10.1016/j.toxlet.2017.07.950
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Propylidene phthalide, regulatory usage limit of 0.01%, is a volatile
liquid that is used in the cosmetics as a fragrance. To deter-
mine dermal absorption, this study was performed according
to Korea Ministry of Food Drug Safety (MFDS) guideline using
LC–MS/MS. The analytical method of propylidene phthalide was
acceptable through method validation of linearity (r2 =0.9994,
y=0.000359 *X+0.00434), precision and accuracy. In this study,
applied formulation on the excided rat skin about 113mg/cm2
was cream containing 0.7% of propylidene phthalide. The stabil-
ity of propylidene phthalide in receptor ﬂuid (50% Ethanol, EtOH)
at 32 ◦C was sufﬁcient for use up to 24h. The times of collected
receptor ﬂuids were set at 0, 1, 2, 4, 8, 12 and 24 hr from recep-
tor chamber. After 24h, remaining formulations on the skin and
stratum corneum (S.C) were collected by swabbing alcohol cotton
and tape stripping, respectively. Collected samples (alcohol cotton,
tape and skin) were extracted by acetonitrile (ACN) for 24h. Total
dermal absorption rates of propylidene phthalidewas calculated to
12.4±2.8%. This data can be used for further exposure assessment
of propylidene phthalide.
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Fibroblasts are key players in the scarring process. In hypertrophic
scars, ﬁbroblasts suffer phenotypical changes into myoﬁbroblasts
persisting in the wound under the inﬂuence of local biochemical
(TGFb1) and biomechanical signaling leading to enhanced imma-
ture extracellular matrix (ECM) synthesis.
Benchtop models of hypertrophic scars rely on scarce human ex
vivo samples or standard 2D cultures of hypertrophic scar ﬁbro-
blasts. We therefore propose the use of human dermal ﬁbroblast
cell sheets (hDFbsCS) as the ﬁrst step to attain cell sheets with
a myoﬁbroblast-like phenotype to generate cohesive in vitro 3D
scar-like tissues.
hDFbsCS were produced as previously described (Cerqueira,
2014), and stimulated with TGFb1 up to 21 days. Following phe-
notype and ECM characterization, 3 hDFbsCS were stacked to
obtain a 3D structure. Gene and protein analysis showed that upon
TGFb1 stimulation, hDFbsCS present a higher expression of aSMA,
ﬁbronectinEDAandEDB, characteristic of amyoﬁbroblast-likephe-
notype. Regarding the expression of scar ECM-associated proteins,
TGFb1 stimulatedhDFbsCSproduced increasedﬁbronectin and col-
lagen I. Upon stacking of hDFbsCS obtained after 7 days of culture
in the presence of TGFb1, stable and integrated 3D constructs were
obtained.
This work suggests that it is possible to create cohesive 3D
scar-like tissue structures from hDFbsCS opening the possibility to
develop in vitro 3D scar models to study wound healing deregula-
tion pathophysiology.
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Human-on-chip technologies are developing rapidly last ﬁve years.
Only fewofavailable systemscapable for cultivationofdifferent cell
types in closed environment, representing humanorgans. Different
end-point analysis techniques are used to test cell function after
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